K. Engh

Design of pH-independent controlled release matrix tablets for acidic drugs.

Y. Qiu, V. Rao, K. Engh, 2003, International journal of pharmaceutics.

Influence of solid phase and formulation processing on stability of Abbott-232 tablet formulations.

D. Law, Y. Qiu, C. Ling, 2006, Journal of pharmaceutical sciences.

Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method.

Y. Qiu, E. Samara, G. Cao, 2003, Journal of pharmaceutical sciences.

Once-a-day controlled-release dosage form of divalproex sodium I: formulation design and in vitro/in vivo investigations.

Y. Qiu, H. Cheskin, K. Engh, 2003, Journal of pharmaceutical sciences.

Sustained-release hydrophilic matrix tablets of zileuton: formulation and in vitro/in vivo studies

Y. Qiu, Yihong Qiu, Howard S. Cheskin, 1997 .

Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity

J. Fields, J. Gordon, G. Drucker, 1991, Pharmacology, Biochemistry and Behavior.

Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): Biphasic dose-response curves

R. Ritzmann, J. Fields, J. Gordon, 1994, Pharmacology Biochemistry and Behavior.